Clinical Trial Update: EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of EXPAREL for fascia iliaca compartment block in intertrochanteric hip fracture was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fractures
• Intertrochanteric Fractures

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Hip Fractures, Intertrochanteric Fractures | Phase 4 | Status: WITHDRAWN